| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |